Adipose-derived factors during nutritional transitions

Current Nutrition and Food Science

Volumn 2, Issue 2, 2006, Pages 127-139

  Bertile, Fabrice ^a   Raclot, Thierry ^a  

^a INSTITUT DE RECHERCHES SUBATOMIQUES   (France)

Author keywords

Adiponectin; Body reserves; Energy homeostasis; Food intake; Leptin; Long term fasting paradigm; Resistin

Indexed keywords

ADIPONECTIN; FATTY ACID; GLUCOSE; LEPTIN; NEUROPEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RESISTIN;

ADIPOCYTE; ADIPOSE TISSUE; BEHAVIOR; BODY WEIGHT; DIET RESTRICTION; ENDOCRINE FUNCTION; ENERGY BALANCE; FEEDING BEHAVIOR; FOOD INTAKE; GENE ACTIVATION; GLUCOSE HOMEOSTASIS; HYPOTHALAMUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 33745856975     PISSN: 15734013     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340106776818862     Document Type: Review

References (232)

1. Flier JS. The adipocyte: storage depot or node on the energy information superhighway? Cell 1995; 80: 15-8.
2. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-32.
3. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: E827-47.
4. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-39.
5. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998; 22: 1145-58.
6. Prins JB. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 2002; 16: 639-51.
7. Frayn KN. Role of non-esterified fatty acids in the metabolic changes of obesity. Int J Obes Relat Metab Disord 1996; 20: 7-10.
8. Coppack SW, Jensen MD, Miles JM . In vivo regulation of lipolysis in humans. J Lipid Res 1994; 35: 177-93.
9. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45: 277-82.
10. Yang YS, Song HD, Li RY, et al. The gene expression profiling of human visceral adipose tissue and its secretory functions. Biochem Biophys Res Commun 2003; 300: 839-46.
11. Li J, Yu X, Pan W, Unger RH. Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. Am J Physiol Endocrinol Metab 2002; 282: E1334-41.
12. Ruan H, Miles PD, Ladd CM, et al. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 2002; 51: 3176-88.
13. Tsuruga H, Kumagai H, Kojima T, Kitamura T. Identification of novel membrane and secreted proteins upregulated during adipocyte differentiation. Biochem Biophys Res Commun 2000; 272: 293-7.
14. Kim S, Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte. J Nutr 2000; 130: 3110S-5S.
15. Ailhaud G. Adipose tissue as an endocrine organ. Int J Obes Relat Metab Disord 2000; 24: S1-3.
16. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002; 13: 51-9.
17. Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 1997; 240: 590-4.
18. Flier JS, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998; 92: 437-40.
19. Loftus TM. An adipocyte-central nervous system regulatory loop in the control of adipose homeostasis. Semin Cell Dev Biol 1999; 10: 11-8.
20. Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. Model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 1999; 69: 584-96.
21. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000; 59: 359-71.
22. Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001; 226: 963-77.
23. Robin JP, Frain M, Sardet C, Groscolas R, Le Maho Y. Protein and lipid utilization during long-term fasting in emperor penguins. Am J Physiol 1988; 254: R61-8.
24. Bertile F, Criscuolo F, Oudart H, Le Maho Y, Raclot T. Differences in the expression of lipolytic-related genes in rat white adipose tissues. Biochem Biophys Res Commun 2003; 307: 540-6.
25. Berfile F, Raclot T. Differences in mRNA expression of adipocyte-derived factors in response to fasting, refeeding and leptin. Biochim Biophys Acta 2004; 1683: 101-9.
26. Bertile F, Raclot T. mRNA levels of SREBP-1c do not coincide with the changes in adipose lipogenic gene expression. Biochem Biophys Res Commun 2004; 325: 827-34.
27. Keesey RE, Hirvonen MD. Body weight set-points: determination and adjustment. J Nutr 1997; 127: 1875S-83S.
28. Harris RB. Role of set-point theory in regulation of body weight. FASEB J 1990; 4: 3310-8.
29. Weigle DS. Appetite and the regulation of body composition. FASEB J 1994; 8: 302-10.
30. Scharrer E, Langhans W. Metabolic and hormonal factors controlling food intake. Int J Vitam Nutr Res 1988; 58: 249-61.
31. Plata-Salaman CR. Regulation of hunger and satiety in man. Dig Dis 1991; 9: 253-68.
32. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc B Biol Sci Lond 1953; 140: 578-92.
33. Woods SC, Seeley RJ. Adiposity signals and the control of energy homeostasis. Nutrition 2000; 16: 894-902.
34. Weigle DS, Hutson AM, Kramer JM, et al. Leptin does not fully account for the satiety activity of adipose tissue-conditioned medium. Am J Physiol 1998; 275: R976-85.
35. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway: a link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28: 619-32.
36. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
37. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-3.
38. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA 1996; 93: 1726-30.
39. Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 1999; 848: 114-23.
40. Bartness JS, Kay Song C, Shi H, Bowers RR, Foster MT. Brain-adipose tissue cross talk. Proc Nutr Soc 2005; 64: 53-64.
41. Fliers E, Kreier F, Voshol PJ, et al. White adipose tissue: getting nervous. J Neuroendocrinol 2003; 15: 1005-1010.
42. Mantzoros CS, Qu D, Frederich RC, et al. ctivation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 1996; 45: 909-14.
43. Migliorini RH, Garofalo MA, Kettelhut IC. Increased sympathetic activity in rat white adipose tissue during prolonged fasting. Am J Physiol 1997; 272: R656-61.
44. Bartness TJ, Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 1998; 275: R1399-411.
45. Kreier F, Fliers E, Voshol PJ, et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat; functional implications. J Clin Invest 2002; 110: 1243-50
46. Le Maho Y, Delclitte P, Chatonnet J. Thermoregulation in fasting emperor penguins under natural conditions. Am J Physiol 1976; 231: 913-22.
47. Goodman MN, Larsen PR, Kaplan MM, Aoki TT, Young VR, Ruderman NB. Starvation in the rat. II. Effect of age and obesity on protein sparing and fuel metabolism. Am J Physiol 1980; 239: E277-86.
48. Cherel Y, Le Maho Y. Refeeding after the late increase in nitrogen excretion during prolonged fasting in the rat. Physiol Behav 1991; 50: 345-9.
49. Belkhou R, Cherel Y, Heitz A, Robin JP, Le Maho Y. Energy contribution of proteins and lipids during prolonged fasting in the rat. Nutr Res 1991; 11: 365-74.
50. Cherel Y, Burnol AF, Leturque A, Le Maho Y. In vivo glucose utilization in rat tissues during the three phases of starvation. Metabolism 1988; 37: 1033-9.
51. Le Maho Y, Vu Van Kha H, Koubi H, Dewasmes G, Girard J, Ferre P, Cagnard M. Body composition, energy expenditure, and plasma metabolites in long-term fasting geese. Am J Physiol 1981; 241: E342-54.
52. Cherel Y, Robin JP, Le Maho Y. Physiology and biochemistry of long term fasting in birds. Can J Zool 1988; 66: 159-66.
53. Groscolas R. In Davis LS, Darby JT Eds, Penguin Biology, Metabolic adaptations to fasting in emperor and king penguins. San Diego, Academic Press. 1990; 269-96.
54. Challet E, Le Maho Y, Robin JP, Malan A, Cherel Y. Involvement of corticosterone in the fasting-induced rise in protein utilization and locomotor activity. Pharmacol Biochem Behav 1995; 50: 405-12.
55. Koubi HE, Robin JP, Dewasmes G, Le Maho Y, Frutoso J, Minaire Y. Fasting-induced rise in locomotor activity in rats coincides with increased protein utilization. Physiol Behav 1991; 50: 337-43.
56. Robin JP, Boucontet L, Chillet P, Groscolas R. Behavioral changes in fasting emperor penguins: evidence for a "refeeding signal" linked to a metabolic shift. Am J Physiol 1998; 274: R746-53.
57. Bertile F, Oudart H, Le Maho Y, Raclot T. Recombinant leptin in the hypothalamic response to late fasting. Biochem Biophys Res Commun 2003; 310: 949-55.
58. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
59. Pond CM. Physiological specialisation of adipose tissue. Prog Lipid Res 1999; 38: 225-48.
60. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev 2001; 2: 239-54.
61. Pond CM, Mattacks CA. The effects of noradrenaline and insulin on lipolysis in adipocytes isolated from nine different adipose depots of guinea-pigs. Int J Obes 1991; 15: 609-18.
62. Jensen MD. Lipolysis: contribution from regional fat. Annu Rev Nutr 1997; 17: 127-39.
63. Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003; 24: 276-83.
64. Amer P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29: 72-5.
65. Stears AJ, Byrne CD. Adipocyte metabolism and the metabolic syndrome. Diabetes Obes Metab 2001; 3: 129-42.
66. Garg A. Lipodystrophies. Am J Med 2000; 108: 143-52.
67. Sugden MC, Grimshaw RM, Lall H, Holness MJ. Regional variations in metabolic responses of white adipose tissue to food restriction. Am J Physiol 1994; 267: E892-9.
68. Kim TS, Freake HC. High carbohydrate diet and starvation regulate lipogenic mRNA in rats in a tissue-specific manner. J Nutr 1996; 126: 611-7.
69. Karbowska J, Kochan Z, Swierczynski J. Increase of lipogenic enzyme mRNA levels in rat white adipose tissue after multiple cycles of starvation-refeeding. Metabolism 2001; 50: 734-8.
70. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N. Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 2002; 34: 622-8.
71. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002; 34: 616-21.
72. Vidal H. Gene expression in visceral and subcutaneous adipose tissues. Ann Med 2001; 33: 547-55.
73. Hauner H. The new concept of adipose tissue function. Physiol Behav 2004; 83: 653-8.
74. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinoloy 2004; 145: 2273-82.
75. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-50.
76. Gottschling-Zeller H, Birgel M, Röhrig K, Hauner H. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture. Metabolism 2000; 49: 666-71.
77. Bastelica D, Morange P, Berthet B, et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002; 22: 173-8.
78. Trayhurn P, Thomas ME, Duncan JS, Rayner DV. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (oblob) mice. FEBS Lett 1995; 368: 488-90.
79. Russell CD, Petersen RN, Rao SP, et al. Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am J Physiol 1998; 275: E507-15.
80. Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47: 913-7.
81. Hube F, Birgel M, Lee Y-M, Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999, 29: 672-8.
82. Hube F, Lietz U, Igel M, et al. Diffrence in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996; 28: 690-3.
83. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46: 342-7.
84. Hausman GJ. In Cryer A, Van RL. Eds, New perspectives in Adipose Tissue: structure, function and development, The comparative anatomy of adipose tissue. London, Butterworths Publishing. 1985; 1-21.
85. Cleland WH, Mendelson CR, Simpson ER. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab 1985; 60: 174-7.
86. Crandall DL, Quinet EM, Morgan GA, Busler DE, McHendry-Rinde B, Kral JG. Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes. J Clin Endocrinol Metab 1999; 84: 3222-7.
87. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808.
88. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
89. Friedman MI. Control of energy intake by energy metabolism. Am J Clin Nutr 1995; 62: 1096S-100S.
90. Friedman MI. Fuel partitioning and food intake. Am J Clin Nutr 1998; 67: 513S-8S.
91. Friedman MI. Body fat and the metabolic control of food intake. Int J Obes 1990; 14: 53-64.
92. Friedman MI, Harris RB, Ji H, Ramirez I, Tordoff MG. Fatty acid oxidation affects food intake by altering hepatic energy status. Am J Physiol 1999; 276: R1046-53.
93. Ji H, Graczyk-Milbrandt G, Friedman MI. Metabolic inhibitors synergistically decrease hepatic energy status and increase food intake. Am J Physiol -Regul Integr Comp Physiol 2000; 278: R1579-R1582.
94. Koch JE, Ji H, Osbakken MD, Friedman MI. Temporal relationships between eating behavior and liver adenine nucleotides in rats treated with 2,5-AM. Am J Physiol Regulatory Integrative Comp Physiol 1998; 274: R610-R617.
95. Horn CC, Ji H, Friedman MI. Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats. Physiol Behav 2004; 81: 157-62.
96. La Fleur SE, Ji H, Manalo SL, Friedman MI, Dallman MF. The hepatic vagus mediates fat-induced inhibition of diabetic hyperphagia. Diabetes 2003; 52: 2321-30.
97. Ji H, Friedman MI. Compensatory hyperphagia after fasting tracks recovery of liver energy status. Physiol Behav 1999; 68: 181-6.
98. Start C, Newsholme EA. The effects of starvation and alloxan-diabetes on the contents of citrate and other metabolic intermediates in rat liver. Biochem J 1968; 107: 411-5.
99. Bernard SF, Mioskowski E, Groscolas R. Blockade of fatty acid oxidation mimics phase II-phase III transition in a fasting bird, the king penguin. Am J Phy 2002; 283: R144-52.
100. Lowell BB, Goodman MN. Protein sparing in skeletal muscle during prolonged starvation. Dependence on lipid fuel availability. Diabetes 1987; 36: 14-9.
101. Raclot T. Selective mobilization of fatty acids from adipose tissue triacylglycerols. Prog Lipid Res 2003; 42: 257-88.
102. Jackson MJ, Papa S, Bolańos J, et al. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. 2002; 23: 209-85.
103. Bhathena SJ. Relationship between fatty acids and the endocrine system. Biofactors 2000; 13: 35-9.
104. Le Marchand-Brustel Y, Gual P, Gremeaux. T, Gonzalez T, Barres R, Tanti JF. Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem Soc Trans 2003; 31: 1152-6.
105. Faraj M, Lu HL, Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 2004; 82: 170-90.
106. Wahle KWJ, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr Soc 2003; 62: 349-60.
107. Raclot T, Oudart H. Selectivity of fatty acids on lipid metabolism and gene expression. Proc Nutr Soc 1999; 58: 633-46.
108. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br J Nutr 2000; 83: S59-66.
109. Hillgartner FB, Salati LM, Goodridge AG. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev 1995; 75: 47-76.
110. Amri EZ, Ailhaud G, Grimaldi PA. Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. J Lipid Res 1994; 35: 930-7.
111. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-88.
112. Debril MB, Renaud JP, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 2001; 79: 30-47.
113. Gilde AJ, Van Bilsen M. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol Scand 2003; 178: 425-34.
114. Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004; 53: S43-50.
115. Kliewer SA, Xu HE, Lambert MH, Willson TM. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 2001; 56: 239-63.
116. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53: 409-35.
117. Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003; 144: 2201-7.
118. Kliewer SA, Sundseth SS, Jones SA, Wahli W, Willson TM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 1997; 94: 4318-23.
119. Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostag Oth Lipid M 2003; 71: 1-22.
120. Tontonoz P, Hu E, Graves R, Budavari A, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-34.
121. Tontonoz; P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARgamma2, a lipid-activated transcription factor. Cell 1994; 79: 1147-56.
122. Chawla A, Schwartz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994; 135: 798-800.
123. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489-98.
124. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 1999; 96: 7473-8.
125. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
126. Ahima RS, Leptin and the neuroendocrinology of fasting. Front Horm Res 2000; 26: 42-56.
127. Friedman JM. Obesity in the new millennium. Nature 2000; 404: 632-4.
128. Flier JS. Clinical review 94: What's in a name? In search of leptin's physiologic role. J Clin Endocrinol Metab 1998; 83: 1407-13.
129. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413-37.
130. Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004; 81: 223-41.
131. Harris RB. Leptin: much more than a satiety signal. Annu Rev Nutr 2000; 20: 45-75.
132. Margetic S, Gazzola C, Pegg GC, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes 2002; 26: 1407-33.
133. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-61.
134. Considine RV, Sinha MY, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
135. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-4.
136. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-9.
137. Havel PJ. Mechanisms regulating leptin production: implications for control of energy balance. Am J Clin Nutr 1999; 70: 305-6.
138. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979; 59: 719-809.
139. Ebihara K, Ogawa Y, Masuzaki H, et al. Transgenic over-expression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 2001; 50: 1440-8.
140. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110: 1093-103.
141. Farooqi S, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New Eng J Med 1999; 341: 879-84.
142. Colombo C, Cutson JJ, Yamauchi T, et al. Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes 2002; 51: 2727-33.
143. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002; 346: 570-8.
144. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002; 109: 1345-50.
145. Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 2003; 26: 30-5.
146. Oral EA, Ruiz E, Andewelt A, Sebring N, Wagner AJ, Depaoli AM, Gorden P. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 2002; 87: 3110-7.
147. Montague CT, Farooqi S, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early onset obesity. Nature 1997; 387: 903-8.
148. Hemysfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults. JAMA 1999; 282: 1568-75.
149. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967: 379-88
150. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-2.
151. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997; 138: 2569-76.
152. Ahima RS, Kelly J, Elmquist JK, Flier JS. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 1999; 140: 4923-31.
153. Nagatani S, Guthikonda P, Thompson RC, Tsukamura H, Maeda KI, Foster DL. Evidence for GnRH regulation by leptin: leptin administration prevents reduced pulsatile LH secretion during fasting. Neuroendocrinology 1998; 67: 370-6.
154. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111: 1409-21.
155. Ahren B, Havel PJ. Leptin increases circulating glucose, insulin and glucagon via sympathetic neural activation in fasted mice. Int I Obes Relat Metab Disord 1999; 23: 660-5.
156. Scarpace PJ, Matheny M, Pollock BH, Turner N. Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol 1997; 273: E226-30.
157. Doring H, Schwarzer K, Nuesslein-Hildesheim B, Schmidt I. Leptin selectively increases energy expenditure of food-restricted lean mice. Int J Obes Relat Metab Disord 1998; 22. 83-8.
158. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002; 87: 2391-4.
159. Lord G. Role of leptin in immunology. Nutr Rev 2002; 60: S35-8.
160. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991; 88: 10931-5.
161. Bertile F, Oudart H, Criscuolo F, Le Maho Y, Raclot T. Hypothalamic gene expression in long-term fasted rats: relationship with body fat. Biochem Biophys Res Commun 2003; 303: 1106-13.
162. Farooqi IS, Keogh JM, Kamath S, et al. Partial leptin deficiency and human adiposity. Nature 2001 ; 414: 34-5.
163. Lombardo YB, Hron WT, Sobocinski KA, Menahan LA. A metabolic profile of fed and fasting genetically obese mice at 4-5 months of age. Horm Metab Res 1984; 16: 37-42.
164. Cherel Y, Robin JP, Heitz A, Calgari C, Le Maho Y. Relationships between lipid availability and protein utilization during prolonged fasting. J Comp Physiol B 1992; 162: 305-13,
165. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 1996; 271: 13939-42.
166. Slieker LJ, Sloop KW, Surface PL, et al. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996; 271: 5301-4.
167. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-9.
168. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-703.
169. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most abundant Gene ranscript 1). Biochem Biophys Res Commun 1996; 221: 286-9.
170. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabet Care 2003; 26: 2442-50.
171. Wolf G. A regulator of energy homeostasis. Nutr Rev 2003; 61: 290-2.
172. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-80.
173. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commum 1999; 257: 79-83.
174. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-9.
175. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
176. Tsao TS, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 2002; 440: 213-21.
177. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-9.
178. Faraj M, Havel PJ, Phelis S, Blanck D, Snideman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594-602.
179. Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003; 88: 4823-31.
180. Gui Y, Silha JV, Mishra S, Murphy LJ. Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance. Can J Physiol Pharmacol 2003; 81: 979-85.
181. Zhang Y, Matheny M, Zolotukhin S, Turner N, Scarpace PJ. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 2002; 1584. 115-22.
182. Ravussin E, Smith SR. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 2002; 967: 363-78.
183. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300.
184. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-7.
185. Combs TP, Pajvani UB, Berg AH, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145: 367-83.
186. Halleux CM, Takahashi M, Delporte ML, et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001; 288: 1102-7.
187. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J Clin Invest 1978; 63: 204-13.
188. Penicaud L, Kande J, Le Magnen J, Girard JR. Insulin action during fasting and refeeding in rat determined by euglycemic clamp. Am J Physiol 1985;249: E514-8.
189. Kruszynska YT, McCormack JG. Effect of nutritional status on insulin sensitivity in vivo and tissue enzyme activities in the rat. Biochem J 1989; 258: 699-707.
190. Le Marchand-Brustel Y, Freychet P. Effect of fasting and streptozotocin diabetes on insulin binding and action in the isolated mouse soleus muscle. J Clin Invest 1979; 64: 1505-14.
191. Qi Y, Takahashi N, Hileman SM, et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10: 524-9.
192. Fruebis S, Javorschi S, Ebbets-Reed D, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Nad Acad Sci USA 2001; 98:2005-10.
193. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-95.
194. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-12.
195. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252-6.
196. Rajala MW, Lin Y, Ranaletta M, et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule- in adipose
197. Hotamisligil GS. The irresistible biology of resistin. J Clin Invest 2003; 111: 173-4.
198. Rea R, Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabet Obes Metab 2004; 6: 163-70.
199. Banerjee RR, Lazar MA. Resistin: molecular history and prognosis. J Mol Med 2003; 81: 218-26.
200. Haugen F, Jorgensen A, Drevon CA, Trayhurn P. Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett 2001; 507: 105-8.
201. Kawashima J, Tsuruzoe K, Motoshima H, et al. Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003; 46: 231-40.
202. Banerjee RR, Rangwala SM, Shapiro JS, et al. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195-8.
203. Juan CC, Au LC, Fang VS, et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001; 289: 1328-33.
204. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992; 71: 1195-204.
205. Cianflone KM, Sniderman AD, Walsh MJ, Vu HT, Gagnon J, Rodriguez MA. Purification and characterization of acylation stimulating protein. J Biol Chem 1989; 264: 426-30.
206. Faraj M, Sniderman AD, Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res 2004; 45: 657-66.
207. Baulande S, Lasnier F, Lucas M, Pairault J. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 2001; 276: 33336-44.
208. Fried SK, DiGirolamo M. Lipoprotein lipase secretion from isolated rat fat cells of different size. Life Sci 1986; 39: 2111-9.
209. Zechner R, Moser R, Newman TC, Fried SK, Breslow JL. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J Biol Chem 1991; 266: 10583-8.
210. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12: 207-33.
211. Braun JE, Severson DL. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J 1992; 287 (Pt 2): 337-47.
212. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
213. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-200.
214. Cassis LA, Saye J, Peach MJ. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988; 11: 591-6.
215. Zorad S, Fickova M, Zelezna B, Macho L, Kral JG. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity. Gen Physiol Biophys 1995; 14: 383-91.
216. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800-3.
217. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997; 78: 656-60.
218. Cook KS, Min HY, Johnson D, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987; 237: 402-5.
219. Doglio A, Dani C, Fredrikson G, Grimaldi P, Ailhaud G. Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation. EMBO J 1987; 6: 4011-6.
220. Chen NX, Hausman GJ, Wright JT. Influence of thyroxine in vivo on preadipocyte development and insulin-like growth factor-I and IGF binding protein secretion in fetal stromal vascular cell cultures. Obes Res 1996; 4: 357-66.
221. Hirokawa J, Sakaue S, Tagami S, et al. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha. Biochem Biophys Res Commun 1997; 235: 94-8.
222. Kratchmarova I, Kalume DE, Blagoev B, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteom 2002; 1: 213-22.
223. Kersten S, Mandard S, Tan NS, et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 2000; 275: 28488-93.
224. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up regulated by insulin and obesity. Endocrinology 2005; 146: 1764-71.
225. Ladu MJ, Kapsas H, Palmer WK. Regulation of lipoprotein lipase in adipose and muscle tissues during fasting. Am J Physiol 1991; 260: R953-9.
226. Fateh-Moghadam A, Schwandt P, Sandel P, Vogt W, Kling S. Effect of total fasting on serum protein concentrations. Klin Wochenschr 1977; 55: 525-31.
227. Cianflone K, Kalant D, Marliss EB, Gougeon R, Sniderman AD. Response of plasma ASP to a prolonged fast. Int J Obes Relat Metab Disord 1995; 19: 604-9.
228. Flier JS, Cook KS, Usher P, Spiegelman BM. Severely impaired adipsin expression in genetic and acquired obesity. Science 1987; 237: 405-8.
229. Frederich RC Jr, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992; 19: 339-44.
230. Massiera F, Bloch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001; 15: 2727-9.
231. Davis RA, Boogaerts JR, Borchardt RA, Malone-McNeal M, Archambault-Schexnayder J. Intrahepatic assembly of very low density lipoproteins. Varied synthetic response of individual apolipoproteins to fasting. J Biol Chem 1985; 260: 14137-44.
232. Takahashi Y, Sato K, Itoh F, Miyamoto, T, Oohashi T, Katoh N. Bovine apolipoprotein E in plasma: increase of ApoE concentration induced by fasting and distribution in lipoprotein fractions. J Vet Med Sci 2003; 65: 199-205.